Rigetti Computing, Inc. (RGTI) › Analysis

Rigetti Computing, Inc. (RGTI) stock analysis, October 1, 2026: RGTI tests $15.65 support after erasing the entire September rally

Published October 1, 2026 · RGTI chart, levels and live analysis

Key Updates

RGTI has declined 8.70% since the September 25, 2026 report, falling from approximately $17.24 to $15.74, fully erasing the prior period's 10.17% surge. The stock is now trading near the levels seen in early September, with the YTD decline widening to -28.94%. The primary news catalyst during this period was the September 8 announcement that the U.S. government acquired minority stakes in Rigetti, D-Wave, and Quantinuum as part of a $300 million CHIPS Act funding deal—a development that was already reflected in the prior report's price action but continues to frame the investment narrative. No new company-specific news has emerged since the last report; the price decline appears driven by profit-taking after the sharp rally and broader sector dynamics, including competitive developments in AI-driven chip design.

Current Trend

RGTI's YTD performance stands at -28.94%, reflecting significant underperformance despite a 22.02% gain over the past six months. The stock has retraced 8.70% since the last report, reversing the entirety of the September rally. Over the past month, the stock is marginally positive (+0.51%), while the five-day decline of -1.66% suggests continued downward momentum. The current price of $15.74 places the stock near its early September support zone around $15.65, a level that previously held and preceded a sharp rebound. The 6-month uptrend remains intact, but the recent pullback highlights the stock's volatility and sensitivity to sector sentiment rather than company-specific fundamentals.

Investment Thesis

The investment thesis for RGTI is anchored in its positioning within the U.S. quantum computing ecosystem, now reinforced by direct government equity participation through the CHIPS Act funding deal. The $300 million allocation with minority stakes in Rigetti, D-Wave, and Quantinuum provides RGTI with both capital and strategic validation from the U.S. government, mitigating some technology commercialization risk. However, the thesis faces headwinds from competitive dynamics in adjacent technologies—specifically, AI-driven chip design startups like Ricursive Intelligence, which are compressing hardware development cycles and could accelerate the pace of quantum-classical integration. The company's YTD decline suggests the market remains skeptical of near-term revenue generation, with the stock trading on sentiment and policy catalysts rather than operational milestones.

Thesis Status

The investment thesis remains intact but has shifted toward a policy-driven narrative. The CHIPS Act funding and minority stake acquisition (announced September 8) provide a tangible floor of institutional support, which was the primary driver of the prior rally. However, the subsequent 8.70% decline indicates that the market has not fully embraced the thesis at higher valuations, and the stock has returned to pre-announcement levels. The thesis status is therefore "neutral-to-constructive"—the fundamental case for government-backed quantum development remains valid, but the absence of fresh operational news and the competitive overhang from AI-driven hardware design tools suggest the market is waiting for clearer evidence of commercial traction before sustaining higher prices.

Key Drivers

• CGI and D-Wave partnership (2026-09-23): Highlights growing enterprise adoption in quantum computing, indirectly supporting the sector's commercial viability case, though it does not directly involve RGTI.

• Ricursive Intelligence's AI chip design (2026-09-25): Represents a competitive threat by reducing hardware development cycles from years to weeks, potentially accelerating the pace of quantum-classical integration and shifting investment toward AI-native approaches.

• CHIPS Act $300M funding with minority stakes (2026-09-08): Direct U.S. government equity in RGTI, D-Wave, and Quantinuum provides strategic validation and capital, a key structural support for the thesis.

• WSJ coverage of the CHIPS Act deal (2026-09-08): Confirms the scope of government involvement, reinforcing the policy tailwind for RGTI.

• Morningstar coverage of the CHIPS Act deal (2026-09-08): Additional confirmation of the funding structure, indicating the deal's significance to multiple financial media outlets.

Technical Analysis

RGTI is trading at $15.74, having retraced 8.70% from the September 25 peak of $17.24. The stock has found support near $15.65, a level that held in early September and preceded a 10% rally. The 5-day decline of -1.66% and the 1-day flat performance suggest the selling pressure is decelerating, potentially setting up a consolidation phase. Key resistance lies at $17.24 (recent high) and then $17.50–$18.00 (prior September resistance). Support levels are $15.65 (current), followed by $15.00 (psychological round number) and $14.50 (August lows). The YTD decline of -28.94% places the stock well below its 2026 highs, but the 6-month gain of +22.02% indicates a broader uptrend remains in place. The current pullback appears to be a retest of the breakout zone, and a hold above $15.65 would confirm the bullish structure.

Bull Case

Bear Case

Get a message when the RGTI picture changes — the agent team watches the levels and the news for you.Create a free account

More RGTI analyses